Immunethep is a biotech startup company that is developing broad coverage anti-bacterial immunotherapies
Immunethep is a biotechnology company focused on drug development for Immune System related pathologies. Immunethep is a spin-off from the University of Porto that uses its proprietary technology to address unmet medical needs.Immunethep discovered a novel mechanism used by different pathogenic bacteria to suppress host immune response. By targeting this mechanism we are developing broad coverage anti-bacterial immunotherapies.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Oct 18, 2022 | Grant | €2.50M | 1 |
European Innovation Council
|
— | Detail |
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
European Innovation Council
|
Yes | Grant |